RxDoctor Payments Data

Rekha Galla, MD

Pain Medicine · Waynesburg, PANPI 1730477381

Payments from drug & device makers

$4,145in general payments, 2019–2025

Across 112 payments — averaging $37.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$1K
  • Genesys Orthopedics Systems, L.L.C.$499
  • Boston Scientific$368
  • Nevro Corp.$166
  • Collegium Pharmaceutical, Inc.$75
  • plus $116 from 4 others

What the payments were for

  • Travel & lodging$1,03425%
  • Food & beverage$3,11175%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,145 in reported general payments places this provider in the 65th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$182,096
Medicare patients
236
Services billed
1,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin887$8,887
NucyntaTapentadol Hcl15$8,687
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen450$4,518
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen476$3,876
Tramadol Hcl646$2,615
Celecoxib140$2,246
Lidocaine26$1,855
Methocarbamol210$1,772
Duloxetine Hcl170$1,748
Tizanidine Hcl124$1,168
Morphine Sulfate ErMorphine Sulfate35$1,034
Diclofenac Sodium104$991
Pregabalin72$936
Oxycodone Hcl128$896
Meloxicam326$695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta$75$8,68715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 294 pain medicine providers in Pennsylvania.

Other pain medicine in Waynesburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →